Bartlett & Co Wealth Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$21.9K 1311
2025
Q4
$21.9K Sell
500
-1,000
-67% -$41.4K ﹤0.01% 807
2025
Q3
$62K Buy
1,500
+1,000
+200% +$40.2K ﹤0.01% 633
2025
Q2
$22K Sell
500
-500
-50% -$20K ﹤0.01% 796
2025
Q1
$36.9K Buy
+1,000
New +$35.6K ﹤0.01% 712
2021
Q3
Sell
-12
Closed -$219 983
2021
Q2
$219 Hold
12
﹤0.01% 1056
2021
Q1
$271 Hold
12
﹤0.01% 1083
2020
Q4
$241 Buy
+12
New +$251 ﹤0.01% 1188

Other funds holding EXEL

Bartlett & Co Wealth Management's EXEL Position: Q1 2026 in Review

Bartlett & Co Wealth Management sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 500 shares — an estimated $21.9K sold.

Bartlett & Co Wealth Management first reported a position in EXEL in Q4 2020 and held it in 7 quarters. The position peaked at $62K in Q3 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Bartlett & Co Wealth Management reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 500 Exelixis shares in Q1 2026, an estimated $21.9K.
  • Bartlett & Co Wealth Management first reported a position in Exelixis in Q4 2020 and held it in 7 quarters.
  • Bartlett & Co Wealth Management's Exelixis position peaked at $62K in Q3 2025.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.